More recently, we constructed an H-1PV silencer expressing shRNAs targeting CDK9 (H-1PV sil-shCDK9), whose expression and activity are often dysregulated in cancer cells, thus contributing to cancer development. The gene discussed is CDK9; the disease is cancer.